In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Relay Therapeutics Inc (NASDAQ: RLAY) closed at $7.50 down -4.58% from its previous closing price of $7.86. In other words, the price has decreased by -$4.58 from its previous closing price. On the day, 2.19 million shares were traded. RLAY stock price reached its highest trading level at $7.86 during the session, while it also had its lowest trading level at $7.32.
Ratios:
For a deeper understanding of Relay Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.64 and its Current Ratio is at 15.64. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 29 ’24 when Catinazzo Thomas sold 10,780 shares for $8.56 per share. The transaction valued at 92,316 led to the insider holds 319,650 shares of the business.
Rahmer Peter sold 15,128 shares of RLAY for $125,260 on Jul 30 ’24. The insider now owns 405,637 shares after completing the transaction at $8.28 per share. On Jul 29 ’24, another insider, Rahmer Peter, who serves as the insider of the company, sold 13,523 shares for $8.54 each. As a result, the insider received 115,543 and left with 420,765 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1218457472 and an Enterprise Value of 366857760. For the stock, the TTM Price-to-Sale (P/S) ratio is 34.61 while its Price-to-Book (P/B) ratio in mrq is 1.47. Its current Enterprise Value per Revenue stands at 10.42 whereas that against EBITDA is -0.997.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is -1.57%, while the 200-Day Moving Average is calculated to be -8.81%.
Shares Statistics:
For the past three months, RLAY has traded an average of 1.87M shares per day and 6014040 over the past ten days. A total of 127.46M shares are outstanding, with a floating share count of 111.73M. Insiders hold about 31.23% of the company’s shares, while institutions hold 55.75% stake in the company. Shares short for RLAY as of 1724976000 were 9065206 with a Short Ratio of 4.85, compared to 1722384000 on 8823988. Therefore, it implies a Short% of Shares Outstanding of 9065206 and a Short% of Float of 8.67.
